LINK; James T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LINK; James T..The latest application filed is for "compounds and methods for selective proteolysis of glucocorticoid receptors".

Company Profile

0.27.37

LINK; James T. - Pearland TX
Link; James T. - Stanford CA
Link; James T. - Standford CA
Link; James T. - Evanston IL
Link; James T. - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds And Methods For Selective Proteolysis Of Glucocorticoid Receptors App 20210361773 - LINK; James T. ; et al.	2021-11-25
Treatment of central nervous system disorders Grant 9,464,072 - Bitner , et al. October 11, 2	2016-10-11
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,290,444 - Bitner , et al. March 22, 2	2016-03-22
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150265613 - Bitner; R. Scott ; et al.	2015-09-24
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,133,145 - Bitner , et al. September 15, 2	2015-09-15
Treatment Of Central Nervous System Disorders App 20150099740 - Bitner; R. Scott ; et al.	2015-04-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,993,632 - Bitner , et al. March 31, 2	2015-03-31
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150065508 - Bitner; R. Scott ; et al.	2015-03-05
Treatment of central nervous system disorders Grant 8,940,902 - Bitner , et al. January 27, 2	2015-01-27
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,716,345 - Bitner , et al. May 6, 2	2014-05-06
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130338169 - Bitner; R. Scott ; et al.	2013-12-19
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,415,354 - Bitner , et al. April 9, 2	2013-04-09
Treatment Of Central Nervous System Disorders App 20130059829 - Bitner; R. Scott ; et al.	2013-03-07
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130045978 - Bitner; R. Scott ; et al.	2013-02-21
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,372,841 - Pliushchev , et al. February 12, 2	2013-02-12
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,314,270 - Link , et al. November 20, 2	2012-11-20
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20120289512 - Bitner; R. Scott ; et al.	2012-11-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,198,331 - Bitner , et al. June 12, 2	2012-06-12
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20120004206 - Pliushchev; Marina A. ; et al.	2012-01-05
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20110218214 - Link; James T. ; et al.	2011-09-08
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,880,001 - Link , et al. February 1, 2	2011-02-01
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,855,308 - Brune , et al. December 21, 2	2010-12-21
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20100222316 - Pliushchev; Marina A. ; et al.	2010-09-02
Treatment Of Central Nervous System Disorders App 20100152179 - Bitner; R. Scott ; et al.	2010-06-17
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,737,137 - Brune , et al. June 15, 2	2010-06-15
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192198 - Bitner; R. Scott ; et al.	2009-07-30
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192141 - Bitner; R. Scott ; et al.	2009-07-30
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090176783 - Bitner; R. Scott ; et al.	2009-07-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20090131434 - Brune; Michael E. ; et al.	2009-05-21
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,528,282 - Rohde , et al. May 5, 2	2009-05-05
Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,521,439 - Bishop , et al. April 21, 2	2009-04-21
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,511,175 - Patel , et al. March 31, 2	2009-03-31
Treatment Of Central Nervous System Disorders App 20090054426 - Bitner; R. Scott ; et al.	2009-02-26
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme App 20080312214 - Yeh; Vince S. ; et al.	2008-12-18
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,435,833 - Yeh , et al. October 14, 2	2008-10-14
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20080076819 - Yeh; Vince S. ; et al.	2008-03-27
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20070179186 - Rohde; Jeffrey J. ; et al.	2007-08-02
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,217,838 - Rohde , et al. May 15, 2	2007-05-15
Novel glucocorticoid receptor ligands for the treatment of metabolic disorders App 20070027117 - Bishop; Richard D. ; et al.	2007-02-01
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme App 20060281773 - Patel; Jyoti R. ; et al.	2006-12-14
Glucocorticoid receptor ligands for the treatment of metabolic disorders Grant 7,141,559 - Bishop , et al. November 28, 2	2006-11-28
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds Grant RE39,197 - Link , et al. July 18, 2	2006-07-18
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme App 20060149070 - Rohde; Jeffrey J. ; et al.	2006-07-06
Metabolic stabilization of substituted adamantane App 20060148871 - Rohde; Jeffrey J. ; et al.	2006-07-06
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050277647 - Link, James T. ; et al.	2005-12-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application App 20050261302 - Hoff, Ethan D. ; et al.	2005-11-24
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050245534 - Link, James T. ; et al.	2005-11-03
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20050245745 - Link, James T. ; et al.	2005-11-03
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application App 20050245532 - Hoff, Ethan D. ; et al.	2005-11-03
Inhibitors of the 11-beta-hydroxysteroid dehydrogenaseType 1 enzyme and their therapeutic application App 20050245533 - Hoff, Ethan D. ; et al.	2005-11-03
Novel glucocorticoid receptor ligands for the treatment of metabolic disorders App 20040235810 - Bishop, Richard D. ; et al.	2004-11-25
Glucagon receptor antagonists/inverse agonists App 20040209928 - Kurukulasuriya, Ravi ; et al.	2004-10-21
Glucocorticoid receptor modulators Grant 6,583,180 - Link , et al. June 24, 2	2003-06-24
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents Grant 6,521,619 - Link , et al. February 18, 2	2003-02-18
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents App 20020156314 - Link, James T. ; et al.	2002-10-24
Glucocorticoid receptor modulators App 20020156311 - Link, James T. ; et al.	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.